What We Do
We’re the independent bridge between pediatric mental health and innovation
Move Founders + Startups
We give fast, credible pediatric evidence and adoption guidance without the hiring overhead.
Support Accelerators + Venture Studios
We help portfolio companies with expert pediatric insight for diligence, growth, and credibility.
Guide Investors + Funders
We provide independent pediatric clinical science audits; scoring to assess safety, fit, and adoption potential and steering you toward essential fixes.
Equip Healthcare Innovators + Product Teams
We deliver expert roadmaps to test, adapt, and scale pediatric tools for research and clinical use.
Our Why
Democratizing Pediatric Clinical Science.
Too many great ideas for kids mental and behavioral health get stuck between discovery and delivery. Academic silos, regulatory hurdles, and fragmented systems keep them from reaching and impacting kids and families when the urgency is accelerating.
Clearview exists to change that.
At Clearview, we pull pediatric clinical science out of the ivory tower and into the hands of innovators and funders.
Our mission is to meet funders and innovators where they are; making pediatric knowledge accessible, independent, and actionable, so safer, scalable mental and behavioral health solutions reach kids faster.
Services at a glance
Services are customized to your team, flat-fee, with clearly defined deliverables—no hourly billing, no ambiguous scopes.
- Big problem: You need a quick, expert read to choose a path.
- Clear solution: A focused working session and a one page memo you can act on.
- What you get: 45 minute session, Founder Signal Memo within 24 hours, 72 hour follow up for questions.
- Timeline: 1 to 2 days total.
- Flat fee: $895.
- Best for: Early scoping, investor questions, sharpening a pitch or pilot ask.
- Big problem: Stakeholders want credible evidence and adoption insight before they commit.
- Clear solution: A detailed, scored review with top fixes and a brief deck you can circulate.
- What you get: Evidence and Adoption scorecards, top recommendations, 3 to 5 slide diligence deck, 60 minute readout, 14 day clarification window.
- Timeline: About 14 business days for a single product or feature.
- Flat fee: $5,900, standard.
- Best for: Founders, CVCs, and accelerators who need a clear yes, no, or fix list.
- Big problem: You need both proof and fit to launch or scale in the real world.
- Clear solution: An integrated plan that connects study design, clinical fit, and adoption strategy.
- What you get: Signal call, Scorecard, integrated roadmap, pilot kit, 90 minute executive readout, 30 days of office hours, optional IC memo.
- Timeline: Typically 4 to 6 weeks based on scope.
- Flat fee: $16,500 to $21,000 depending on complexity.
- Best for: Teams preparing for pilots, strategic partnerships, or an Investment Committee decision.
Learn more about our services
The Clearview Advantage
Credibility = Fundability
70% of healthcare investors cite clinical validation as their top funding driver.1,2
Without it, companies systematically lose funding dollars, market adoption, trust, and clinical impact. 3,4
Our doctoral-level experts give you investor-ready pediatric validation.
Fastrack Clinical Readiness
Approximately 60% of digital health pilots stall because of barriers like poor data readiness and mismatch to real-life workflow.5,6
Failed pilots waste $500K+ on average and stall market entry.6
We clear adoption barriers early so your product scales in real clinical use.
Safety & Ethical Assurance
2 out of 3 pediatric health tools skips validation. 7
The result? Millions lost in failed partnerships and an average 6-12 month delay in funding, launch, and adoption by the market. 7,8
Our plans build safety and ethics in from the start — protecting both dollars and traction.
Impact Spotlights
Pediatric insight that works in the real world
Challenge: A digital health team building a pediatric VR device wasn’t sure which features would actually deliver value for kids managing symptoms.
Our Impact: We delivered strategic consultation to align the program with child development principles and optimize it for clinical and real-world fit.
Result: They sharpened strategy and successfully secured funding from an NIH-accelerator.
Challenge: A team building a pediatric resilience intervention needed expert input to refine strategy and ensure developmental and clinical soundness.
Our Impact: Clearview pediatric psychologists provided strategic consultation to align the program with child development principles and optimize it for clinical and real-world fit.
Result: The resilience intervention advanced with sharper strategy and stronger grounding in evidence-based pediatric psychology, sailing through the next funding phase and moving toward clinical adoption seamlessly.
Challenge: A pediatric team needed to evolve their chronic pain program for youth to fit youth with overlapping conditions and new science.
Our Impact: In less than three weeks, we guided updates to both parent and child content, ensuring inclusivity, developmental soundness, and behavioral science alignment.
Result: The program pivoted successfully and is now rolling out to more than 30 children’s hospitals across three continents.
What We Do
Provide independent PhD-level evidence and readiness guidance.
Deliver flat-fee, outcome-based services to advance great pediatric behavioral health products or services with no hidden costs.
De-risk pediatric mental and behavioral health products for real-world use with kids, families, systems, and funders.
Tailor insights to your stage: early proof, pediatric rollout readiness, or full pilot/adoption roadmap.
What We Don’t Do
Deliver direct treatment or clinical care.
Provide services on behalf of any single institution. We connect objective, rigorous, insider-trained minds at the top of their fields directly to your solution and team, independent of institutional red tape.
Bill by the hour or leave scope unclear. No open-ended consulting.
Push “one-size-fits-all” advice. Every engagement is project-specific.
De-risk. Validate. Scale.
Your next pediatric success starts here.
Footnotes
- Norden J., Clinical validation will save digital health’s reputation (STAT, Aug 16 2022).
- Khozin, AI in Drug Development: Clinical Validation and Regulatory Innovation Are Dual Imperatives, DIA Global Forum, June 2025
- Carroll AR, Hall M, Harris M, et al. Validation of 30-Day Pediatric Hospital Readmission Risk Prediction Models. JAMA Netw Open. 2025;8(2):e2459684. doi:10.1001/jamanetworkopen.2024.59684
- Digital Medicine Society, “Seeing the Bigger Picture: Unlocking Value for Payors and Investors,” The Playbook: Pediatric Digital Medicine, February 25, 2025, Digital Medicine Society (DiMe).
- Borges do Nascimento IJ, et al. “The global effect of digital health technologies on health workers’ competencies and health workplace: an umbrella review of systematic reviews and lexical-based and sentence-based meta-analysis.” The Lancet Digital Health, Vol. 5, No. 8, 2023, pp. e534–e544.
- Bata SA, Richardson T. Value of Investment as a Key Driver for Prioritization and Implementation of Healthcare Software. Perspect Health Inf Manag. 2018 Jan 1;15(Winter):1g. PMID: 29618963; PMCID: PMC5869444.
- Kurbatfinski S, Komanchuk J, Dosani A, Letourneau N. Validity, Reliability, Accessibility, and Applicability of Young Children’s Developmental Screening and Assessment Tools across Different Demographics: A Realist Review. Children (Basel). 2024 Jun 18;11(6):745. doi: 10.3390/children11060745. PMID: 38929324; PMCID: PMC11201752.
- Tran A., Valo P., Rouvier C., et al. “Validation of the Computerized Pediatric Triage Tool, pediaTRI, in the Pediatric Emergency Department of Lenval Children’s Hospital in Nice: A Cross-Sectional Observational Study.” Frontiers in Pediatrics, vol. 10, 2022.